Pink Sheets

Xechem International, Inc. is a holding company that owns all of the capital stock of Xechem, Inc., a development stage biopharmaceutical company engaged in the research and technology development of generic and drugs from natural sources. Research and development efforts focus principally on antifungal, anticancer, antiviral (including anti-AIDS) and anti-inflammatory compounds, as well as anti-aging and memory enhancing compounds. Xechem is also focusing on phytopharmaceuticals and other technologies for orphan diseases. As of December 31, 2006, the Company's lead project involved the development of a phytopharmaceutical product, NICOSAN/HEMOXIN). The development and production of NICOSAN/HEMOXIN is being conducted through Xechem Nigeria, Xechem Research Laboratories of Xechem, Inc. and Children’s Hospital of Philadelphia. In November 2008, the Company, along with Xechem, filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code.
379 Thornall
Edison, NJ 08818
United States - Map
+1-732-2050500 (Phone)
+1-732-2474090 (Fax)


Copyright  2011